期刊文献+

莨菪碱注射液辅助阿奇霉素序贯治疗小儿支原体肺炎的疗效研究 被引量:9

Clinical efficacy and mechanism of scopolamine injection assisted with azithromycin sequential therapy on children with mycoplasma pneumonia
下载PDF
导出
摘要 目的探讨莨菪碱注射液辅助阿奇霉素序贯治疗小儿支原体肺炎的临床疗效及对患儿肺功能、细胞免疫功能的影响。方法选取湖南省人民医院及拉萨市人民医院接诊的支原体肺炎患儿178例,随机分为联合组和阿奇霉素组,每组89例。阿奇霉素组给予阿奇霉素序贯治疗+基础治疗,联合组在阿奇霉素组基础上加用莨菪碱注射液肺腧穴注射。比较两组临床疗效、肺功能、细胞免疫功能的变化。结果治疗后,联合组临床疗效优于阿奇霉素组(P<0.05);联合组用力肺活量(FVC)、第1秒用力呼气量(FEV1)、最高呼气峰流速(PEF)均高于阿奇霉素组(P<0.05);联合组血清CD3+、CD4+水平高于阿奇霉素组,CD8+低于阿奇霉素组(P<0.05);联合组单核细胞趋化蛋白-4(MCP-4)、半胱氨酰白三烯(CysLTs)及细胞间黏附分子-1(ICAM-1)质量浓度均低于阿奇霉素组,Clara细胞分泌蛋白(CCSP)高于阿奇霉素组(P<0.05)。结论莨菪碱注射液辅助阿奇霉素序贯治疗小儿支原体肺炎疗效好,可改善肺功能和细胞免疫功能,促进患儿康复。 Objective To explore the clinical efficacy of scopolamine injection assisted with azithromycin sequential therapy for mycoplasma pneumonia (MPP) in children and its effects on pulmonary function and cellular immune function.Methods Totally 178 cases of MPP patients admitted to Hunan Provincial People’s Hospital and Lhasa People’s Hospital were randomly divided into the combined group (n=89) and the azithromycin group (n=89).The azithromycin group was given azithromycin sequential therapy and basic therapy,and the combined group was additionally given scopolamine injection via Feishu point.The clinical efficacy,pulmonary function and cellular immune function were compared between the two groups.Results After treatment,the clinical efficacy in the combined group was better than that in the azithromycin group (P < 0.05).The forced vital capacity (FVC),forced expiratory volume in 1 second (FEV1) and peak expiratory flow (PEF) in the combined group were significantly higher than those in the azithromycin group (P < 0.05).The levels of serum CD3^+,CD4^+,and Clara cell secretory protein (CCSP) in the combined group were significantly higher than those in the azithromycin group (P < 0.05).The levels of serum CD8^+,monocyte chemoattractant protein-4 (MCP-4),cysteinyl leukotriene (CysLTs),and intercellular adhesion molecule-1 (ICAM-1) in the combined group were lower than those in the azithromycin group.Conclusions Scopolamine injection assisted with azithromycin sequential therapy for MMP children has significant efficacy,which can effectively improve pulmonary function and cellular immune function,and promote the rehabilitation of MMP children.
作者 杨钦 德吉卓嘎 谌亮 贾晓敏 Qin Yang;Dejizhuoga;Liang Chen;Xiao-min Jia(Medical Department,Hunan Provincial People’s Hospital(The First Hospital Affiliated to Hunan Normal University),Changsha,Hunan 410005,China;Department of Pathology,Lhasa People's Hospital,Lhasa,Tibet 850000,China;Cardiopulmonary Function Testing Center,Hunan Provincial Tumor Hospital(Tumor Hospital Affiliated to Xiangya School of Medicine,Hospital Central South University),Changsha,Hunan 410013,China)
出处 《中国现代医学杂志》 CAS 2020年第21期74-77,共4页 China Journal of Modern Medicine
关键词 支原体 肺炎 莨菪碱 阿奇霉素 序贯治疗 pneumonia mycoplasma scopolamine azithromycin sequential therapy
  • 相关文献

参考文献13

二级参考文献102

  • 1郝丽,郑成中.支原体肺炎患儿D-二聚体、免疫功能变化及其意义[J].中国生化药物杂志,2014,34(3):156-159. 被引量:34
  • 2王素霞,王静,任常军,张晶,韦翊.阿奇霉素序贯疗法治疗小儿支原体肺炎的疗效和安全性分析[J].中国生化药物杂志,2014,34(5):132-134. 被引量:137
  • 3谢建伟.博利康尼佐治小儿支原体肺炎30例[J].海南医学,2007,18(8):107-107. 被引量:2
  • 4胡亚美,江载芳.诸福棠实用儿科学[M].7版人民卫生出版社,2002:1204-1205.
  • 5Klein JO. Clarithromycin and azithromycin [ J ]. Pediatr Infect Dis, 1998,17:516 -517.
  • 6Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children [ J ]. Pediatr Pulmonol, 2006,41:263 - 268.
  • 7Youn Y S,Lee S C,Rhim J W,et al.Early additional immune-modulators for mycoplasma pneumoniae pneumonia in children:an observation study[J].Infect Chemother,2014,46(4):239.
  • 8Ye Q,Xu X J,Shao W X,et al.Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases[J].Scientific World Journal,2014,2014:986527.
  • 9Meyer Sauteur P M,Jacobs B C,Spuesens E B,et al.Antibody responses to mycoplasma pneumoniae:role in pathogenesis and diagnosis of encephalitis[J].PLo S Pathog,2014,10(6):e1003983.
  • 10Izumikawa K,Izumikawa K,Takazono T,et al.Clinical features,risk factors and treatment of fulminant Mycoplasma pneumoniae pneumonia:a review of the Japanese literature[J].J Infect Chemother,2014,20(3):181.

共引文献520

同被引文献124

引证文献9

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部